Trends and characteristics during 17 years of naloxone distribution and administration through an overdose prevention program in Pittsburgh, Pennsylvania
PLOS One · 24.10.2025 · 20 (10) · e0315026
DOI: 10.1371/journal.pone.0315026 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 24.10.2025. Verfasst von Nabarun Dasgupta und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina, Chapel Hill, North Carolina, United States of America. Hauptthemen laut MEDLINE: Naloxone, Drug Overdose, Narcotic Antagonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: U.S. Food and Drug Administration.
Abstract (Originalsprache)
Objective
Describe time trends during 17.5 years of community-based naloxone distribution Methods Analysis of administrative records from a harm reduction program in Pittsburgh, Pennsylvania, USA, collected during encounters for overdose education, naloxone dispensing and refills. Monthly time trends were analyzed using segmented regression. Programmatic context aided interpretation of quantitative findings. We also evaluated impacts of 2014 state legislation loosening naloxone prescribing requirements and providing Good Samaritan protections.
Results
From July 2005 to January 2023 there were 16,904 service encounters by 7,582 unique participants, resulting in 70,234 naloxone doses dispensed, with 5,521 overdose response events (OREs), utilizing 8,756 naloxone doses. After legislation, new participants increased from 10.4 to 65.9 per month. New participants tended to be older (46 vs. 37 years), female (58% to 35%), White race, and more likely to be family/friends as opposed to people who use drugs themselves. Consequently, ORE per participant fell from 1.46 to 0.47 in the year after enactment. On average, 1.63 (95% CI: 1.60, 1.65) naloxone doses were administered per ORE, which did not change substantially over 17 years ( χ 2 = 0.28, 3 df, p = 0.60) during evolution from prescription opioids, to heroin, to illicitly manufactured fentanyl. In 98.0% of OREs the person who experienced overdose “was okay”, i.e., survived. Emergency medical services were called in 16% of OREs overall, but
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of North Carolina, Chapel Hill, North Carolina, United States of America.
- Remedy Alliance For The People, Berkeley, California, United States of America.
- Prevention Point Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
- US Food and Drug Administration, Silver Spring, Maryland, United States of America.
ORCID-Profile: Nabarun Dasgupta, Summer Barlow
Förderung
- U.S. Food and Drug Administration
Zitieren
APA
Dasgupta, N., Bell, A., Visnich, M., Doe-Simkins, M., Wheeler, E., Sibley, A. L., Nocera, M., Seitz, A. E., Chang, D., Barlow, S., Dezman, Z. D. W., & McAninch, J. K. (2025). Trends and characteristics during 17 years of naloxone distribution and administration through an overdose prevention program in Pittsburgh, Pennsylvania. PLOS One, 20(10), e0315026. https://doi.org/10.1371/journal.pone.0315026
Vancouver
Dasgupta N, Bell A, Visnich M, Doe-Simkins M, Wheeler E, Sibley AL, et al. Trends and characteristics during 17 years of naloxone distribution and administration through an overdose prevention program in Pittsburgh, Pennsylvania. PLOS One. 2025;20(10):e0315026. doi:10.1371/journal.pone.0315026
BibTeX
@article{Dasgupta2025,
author = {Dasgupta, Nabarun and Bell, Alice and Visnich, Malcolm and Doe-Simkins, Maya and Wheeler, Eliza and Sibley, Adams L and Nocera, Maryalice and Seitz, Amy E and Chang, Dorothy and Barlow, Summer and Dezman, Zachary D W and McAninch, Jana K},
title = {Trends and characteristics during 17 years of naloxone distribution and administration through an overdose prevention program in Pittsburgh, Pennsylvania},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {10},
pages = {e0315026},
doi = {10.1371/journal.pone.0315026}
}
EUVIMED